Central Pharmaceutical Joint Stock Company No3: Q2/2025 net profit increased to VND 32.10 billion as margins and cash flow improved

About this update from Central Pharmaceutical Jsc No. 3

Net profit after tax for Q2/2025 rose to VND 32.10 billion despite a year-over-year revenue decline, with improved gross margin and strong operating cash flow supporting financial stability.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Central Pharmaceutical Jsc No. 3